ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,981 | -34.7% | 24,915 | +2.3% | 0.00% | 0.0% |
| Q2 2023 | $121,029 | -2.3% | 24,352 | -2.9% | 0.00% | 0.0% |
| Q1 2023 | $123,851 | -19.1% | 25,071 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $153,143 | -39.5% | 24,347 | +4.0% | 0.00% | -66.7% |
| Q3 2022 | $253,000 | -4.5% | 23,414 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $265,000 | +37.3% | 23,212 | +9.6% | 0.00% | +50.0% |
| Q1 2022 | $193,000 | -38.5% | 21,188 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $314,000 | -42.4% | 21,048 | -0.7% | 0.00% | -50.0% |
| Q3 2021 | $545,000 | -0.5% | 21,205 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $548,000 | -15.6% | 21,028 | +14.4% | 0.00% | -33.3% |
| Q1 2021 | $649,000 | +41.4% | 18,376 | +1.1% | 0.01% | +50.0% |
| Q4 2020 | $459,000 | -28.5% | 18,177 | +6.8% | 0.00% | -33.3% |
| Q3 2020 | $642,000 | +18.2% | 17,016 | +34.1% | 0.01% | -25.0% |
| Q2 2020 | $543,000 | – | 12,687 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |